• 1
    Melton LJ III, Chao EYS, Lane J, 1988 Biomechanical aspects of fractures. In: RiggsBL, MeltonLJIII, (eds.) Osteoporosis: Etiology, Diagnosis, and Management. Raven Press, New York, NY, U.S.A., pp. 111131.
  • 2
    Hayes WC, Myers ER, 1995 Biomechanics of fractures. In: RiggsBL, MeltonLJIII, (eds.) Osteoporosis: Etiology, Diagnosis, and Management, 2nd Ed. Lippincott-Raven Publishers, Philadelphia, PA, U.S.A., pp. 93114.
  • 3
    Riggs BL, Melton LJ III, O'Fallon WM 1996 Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy Bone 18:197S201S.
  • 4
    Hansen MA, Overgaard K, Riis BJ, Christiansen C 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study Br Med J 303:961964.
  • 5
    Parfitt AM 1984 Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical consequences Calcif Tissue Int 36:S123S128.
  • 6
    Einhorn TA 1992 Bone strength: The bottom line Calcif Tissue Int 51:333339.
  • 7
    Delmas PD, 1995 Biochemical markers for the assessment of bone turnover. In: RiggsBL, MeltonLJIII, (eds.) Osteoporosis: Etiology, Diagnosis, and Management, 2nd Ed. Lippincott-Raven Publishers, Philadelphia, PA, U.S.A., pp. 319333.
  • 8
    Delmas P, Stenner D, Wahner HW, Mann KG, Riggs BL 1983 Increase in serum bone γ-carboxyglutamic acid protein with aging in women: Implications for the mechanism of age-related bone loss J Clin Invest 71:13161321.
  • 9
    Epstein S, Poser J, McClintock R, Johnston CC Jr, Bryce G, Hui S 1984 Differences in serum bone Gla-protein with age and sex Lancet 1:307310.
  • 10
    Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F 1993 Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease J Bone Miner Res 8:643648.
  • 11
    Garnero P, Sornay-Rendu E, Chapuy M-C, Delmas PD 1996 Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis J Bone Miner Res 11:337349.
  • 12
    Garnero P, Hausherr E, Chapuy M-C, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study J Bone Miner Res 11:15311538.
  • 13
    Melton LJ III 1996 History of the Rochester Epidemiology Project Mayo Clin Proc 71:266274.
  • 14
    Cosman F, Nieves J, Wilkinson C, Schnering D, Shen V, Lindsay R 1996 Bone density change and biochemical indices of skeletal turnover Calcif Tissue Int 58:236243.
  • 15
    Khosla S, Atkinson EJ, Melton LJ III, Riggs BL, 1997 Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population based study. J Clin Endocrinol Metab (in press).
  • 16
    Melton LJ III, Khosla S, 1998 Osteoporosis. In: FraserI, JansenR, LoboR, WhiteheadM, (eds.) Estrogen and Progestogens in Clinical Practice. Churchill Livingstone, London, U.K. (in press).
  • 17
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 Perspective: The diagnosis of osteoporosis J Bone Miner Res 9:11371141.
  • 18
    Duda RJ Jr, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL 1988 Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: Effect of sex, age, and metabolic bone disease J Clin Endocrinol Metab 66:951957.
  • 19
    Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russell RGG 1993 Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption Osteoporos Int 3:255260.
  • 20
    Kotowicz MA, Melton LJ III, Cedel SL, O'Fallon WM, Riggs BL 1990 Effect of age on variables relating to calcium and phosphorus metabolism in women J Bone Miner Res 5:345352.
  • 21
    Eastell R, Simmons PS, Colwell A, Assiri AMA, Burritt MF, Russell RGG, Riggs BL 1992 Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: Effects of growth and ageing Clin Sci 83:375382.
  • 22
    Garnero P, Delmas PD 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease J Clin Endocrinol Metab 77:10461053.
  • 23
    Sone T, Miyake M, Takeda N, Fukunaga M 1995 Urinary excretion of Type I collagen crosslinked N-telopeptides in healthy Japanese adults: Age- and sex-related changes and reference limits Bone 17:335339.
  • 24
    Sherman SS, Tobin JD, Hollis BW, Gundberg CM, Roy TA, Plato CC 1992 Biochemical parameters associated with low bone density in healthy men and women J Bone Miner Res 7:11231130.
  • 25
    Mole PA, Walkinshaw MH, Robins SP, Paterson CR 1992 Can urinary pyridinium crosslinks and urinary oestrogens predict bone mass and rate of bone loss after the menopause? Eur J Clin Invest 22:767771.
  • 26
    Ravn P, Fledelius C, Rosenquist C, Overgaard K, Christiansen C 1996 High bone turnover is associated with low bone mass in both pre- and postmenopausal women Bone 19:291298.
  • 27
    Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment J Clin Endocrinol Metab 79:16931700.
  • 28
    Slemenda C, Hui SL, Longcope C, Johnston CC 1987 Sex steroids and bone mass: A study of changes about the time of menopause J Clin Invest 80:12611269.
  • 29
    Johansen JS, Riis BJ, Delmas PD, Christiansen C 1988 Plasma BGP: An indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women Eur J Clin Invest 18:191195.
  • 30
    Eastell R, Hampton L, Colwell A, Green JR, Assiri AMA, Hesp R, Russell RGG, Reeve J, 1990 Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. In: ChristiansenC, OvergaardK, (eds.) Osteoporosis, Osteopress Aps, Copenhagen, Denmark, pp. 469470.
  • 31
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links J Clin Endocrinol Metab 72:367373.
  • 32
    Riis BJ 1995 The role of bone loss Am J Med 98(Suppl 2A):2A29S-2A-32S.
  • 33
    Drezner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL 1996 Biochemical markers of bone turnover reflect femoral bone loss in elderly women Calcif Tissue Int 59:328333.
  • 34
    Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R 1993 Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis J Bone Miner Res 8:881889.
  • 35
    Fledelius C, Riis BJ, Overgaard K, Christiansen C 1994 The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis Calcif Tissue Int 54:381384.
  • 36
    Riis BJ, Overgaard K, Christiansen C 1995 Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy Osteoporos Int 5:276280.
  • 37
    Satoh Y, Soeda Y, Dokou S 1995 Analysis of relationships between sex hormone dynamics and bone metabolism and changes in bone mass in surgically induced menopause Calcif Tissue Int 57:258266.
  • 38
    Ooms ME, Lips P, Roos JC, Van Der Vijgh WJF, Popp-Snijders C, Bezemer PD, Bouter LM 1995 Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women J Bone Miner Res 10:11771184.
  • 39
    Brazier M, Kamel S, Maamer M, Agbomson F, Elesper I, Garabedian M, Desmet G, Sebert JL 1995 Markers of bone remodeling in the elderly subject: Effects of vitamin D insufficiency and its correction J Bone Miner Res 10:17531761.
  • 40
    McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL 1996 Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption J Clin Endocrinol Metab 81:16991703.
  • 41
    Heaney RP 1996 Editorial: Calcium, parathyroid function, bone, and aging J Clin Endocrinol Metab 81:16971698.
  • 42
    Åkesson K, Ljunghall S, Gärdsell P, Sernbo I, Obrant KJ 1993 Serum osteocalcin and fracture susceptibility in elderly women Calcif Tissue Int 53:8690.
  • 43
    Mallmin H, Ljunghall S, Larsson K 1993 Biochemical markers of bone metabolism in patients with fracture of the distal forearm Clin Orthop 295:259263.
  • 44
    Delmas PD, Wahner HW, Mann KG, Riggs BL 1983 Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein J Lab Clin Med 102:470476.
  • 45
    Åkesson K, Vergnaud P, Gineyts E, Delmas PD, Obrant KJ 1993 Impairment of bone turnover in elderly women with hip fracture Calcif Tissue Int 53:162169.
  • 46
    Benhamou CL, Tourliere D, Gauvain JB, Picaper G, Audran M, Jallet P 1995 Calciotropic hormones in elderly people with and without hip fracture Osteoporos Int 5:103107.
  • 47
    Cheung CK, Panesar NS, Lau E, Woo J, Swaminathan R 1995 Increased bone resorption and decreased bone formation in Chinese patients with hip fracture Calcif Tissue Int 56:347349.
  • 48
    Åkesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gärdsell P, Obrant KJ 1995 Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women J Bone Miner Res 10:18231829.
  • 49
    van Daele PLA, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JPTM, Birkenhäger JC, Pols HAP 1996 Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam study Br Med J 312:482483.
  • 50
    Hui SL, Slemenda CW, Johnston CC Jr 1990 The contribution of bone loss to postmenopausal osteoporosis Osteoporos Int 1:3034.
  • 51
    Christiansen C 1994 Postmenopausal bone loss and the risk of osteoporosis Osteoporos Int 4 (Suppl 1):S47S51.